GILD vs. JNJ
Compare and contrast key facts about Gilead Sciences, Inc. (GILD) and Johnson & Johnson (JNJ).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: GILD or JNJ.
Correlation
The correlation between GILD and JNJ is 0.46, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.
Performance
GILD vs. JNJ - Performance Comparison
Loading data...
Key characteristics
GILD:
2.11
JNJ:
0.06
GILD:
3.01
JNJ:
0.35
GILD:
1.38
JNJ:
1.05
GILD:
1.92
JNJ:
0.18
GILD:
10.43
JNJ:
0.49
GILD:
5.49%
JNJ:
6.54%
GILD:
27.11%
JNJ:
19.20%
GILD:
-70.82%
JNJ:
-52.60%
GILD:
-12.09%
JNJ:
-11.11%
Fundamentals
GILD:
$124.92B
JNJ:
$359.97B
GILD:
$4.86
JNJ:
$9.19
GILD:
20.65
JNJ:
16.28
GILD:
0.21
JNJ:
1.02
GILD:
4.35
JNJ:
4.03
GILD:
6.52
JNJ:
4.61
GILD:
$28.73B
JNJ:
$89.33B
GILD:
$23.07B
JNJ:
$61.01B
GILD:
$9.89B
JNJ:
$34.70B
Returns By Period
In the year-to-date period, GILD achieves a 11.75% return, which is significantly higher than JNJ's 5.48% return. Over the past 10 years, GILD has underperformed JNJ with an annualized return of 2.72%, while JNJ has yielded a comparatively higher 6.76% annualized return.
GILD
11.75%
-2.27%
17.75%
56.72%
10.49%
2.72%
JNJ
5.48%
-1.68%
-0.15%
1.23%
2.97%
6.76%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
GILD vs. JNJ — Risk-Adjusted Performance Rank
GILD
JNJ
GILD vs. JNJ - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Gilead Sciences, Inc. (GILD) and Johnson & Johnson (JNJ). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Loading data...
Dividends
GILD vs. JNJ - Dividend Comparison
GILD's dividend yield for the trailing twelve months is around 3.02%, less than JNJ's 3.28% yield.
| TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
GILD Gilead Sciences, Inc. | 3.02% | 3.33% | 3.70% | 3.40% | 3.91% | 4.67% | 3.88% | 3.65% | 2.90% | 2.57% | 1.27% | 0.00% |
JNJ Johnson & Johnson | 3.28% | 3.40% | 3.00% | 2.52% | 2.45% | 2.53% | 2.57% | 2.74% | 2.38% | 2.73% | 2.87% | 2.64% |
Drawdowns
GILD vs. JNJ - Drawdown Comparison
The maximum GILD drawdown since its inception was -70.82%, which is greater than JNJ's maximum drawdown of -52.60%. Use the drawdown chart below to compare losses from any high point for GILD and JNJ. For additional features, visit the drawdowns tool.
Loading data...
Volatility
GILD vs. JNJ - Volatility Comparison
Gilead Sciences, Inc. (GILD) has a higher volatility of 11.99% compared to Johnson & Johnson (JNJ) at 6.41%. This indicates that GILD's price experiences larger fluctuations and is considered to be riskier than JNJ based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading data...
Financials
GILD vs. JNJ - Financials Comparison
This section allows you to compare key financial metrics between Gilead Sciences, Inc. and Johnson & Johnson. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
GILD vs. JNJ - Profitability Comparison
GILD - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Gilead Sciences, Inc. reported a gross profit of 5.71B and revenue of 6.67B. Therefore, the gross margin over that period was 85.6%.
JNJ - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Johnson & Johnson reported a gross profit of 14.54B and revenue of 21.89B. Therefore, the gross margin over that period was 66.4%.
GILD - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Gilead Sciences, Inc. reported an operating income of 3.15B and revenue of 6.67B, resulting in an operating margin of 47.2%.
JNJ - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Johnson & Johnson reported an operating income of 6.30B and revenue of 21.89B, resulting in an operating margin of 28.8%.
GILD - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Gilead Sciences, Inc. reported a net income of 1.32B and revenue of 6.67B, resulting in a net margin of 19.7%.
JNJ - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Johnson & Johnson reported a net income of 11.00B and revenue of 21.89B, resulting in a net margin of 50.2%.